Guydish Joseph, Tajima Barbara, Pramod Sowmya, Le Thao, Gubner Noah R, Campbell Barbara, Roman Paul
Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States.
Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States.
Drug Alcohol Depend. 2016 Sep 1;166:93-9. doi: 10.1016/j.drugalcdep.2016.06.035. Epub 2016 Jul 14.
To explore use of tobacco products in relationship to marketing exposure among persons in addiction treatment.
A random sample of treatment programs was drawn from the National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN). Participants in each program completed surveys concerning use of tobacco products (N=1113). Exposure to tobacco marketing and counter-marketing, advertising receptivity, and perceived health risks of smoking were tested for their association with use of multiple tobacco products.
Prevalence of combustible cigarette use was 77.9%. Weekly or greater use of other products was: e-cigarettes (17.7%), little filtered cigars (8.6%), smokeless tobacco (5.2%), and standard cigars (4.6%) with 24.4% using multiple tobacco products. Compared to single product users, multiple product users smoked more cigarettes per day (OR=1.03, 95% CI 1.01-1.05, p<0.001), were more likely to have tried to quit (OR=1.41, 95% CI 1.02-1.96, p=0.041), reported greater daily exposure to advertising for products other than combustible cigarettes (OR=1.93, CI 1.35-2.75, p<0.001), and greater daily exposure to tobacco counter-marketing (OR=1.70, 95% CI: 1.09-2.63, p=0.019).
Heavier smokers and those trying to quit may be more likely to use e-cigarettes, little filtered cigars, or smokeless tobacco and have greater susceptibility to their advertising. This highlights the importance of regulating advertising related to smoking cessation as their effectiveness for this purpose has not been demonstrated.
探讨成瘾治疗患者中烟草制品使用情况与营销接触之间的关系。
从美国国立药物滥用研究所(NIDA)临床试验网络(CTN)中抽取治疗项目的随机样本。每个项目的参与者完成了关于烟草制品使用情况的调查(N = 1113)。测试了烟草营销与反营销、广告接受度以及吸烟的感知健康风险与多种烟草制品使用之间的关联。
可燃香烟的使用率为77.9%。每周或更频繁使用其他产品的比例为:电子烟(17.7%)、小雪茄(8.6%)、无烟烟草(5.2%)和标准雪茄(4.6%),24.4%的人使用多种烟草制品。与单一产品使用者相比,多种产品使用者每天吸烟更多(比值比[OR]=1.03,95%置信区间[CI] 1.01 - 1.05,p<0.001),更有可能尝试戒烟(OR = 1.41,95% CI 1.02 - 1.96,p = 0.041),报告每天接触可燃香烟以外产品广告的频率更高(OR = 1.93,CI 1.35 - 2.75,p<0.001),以及每天接触烟草反营销的频率更高(OR = 1.70,95% CI:1.09 - 2.63,p = 0.019)。
重度吸烟者和试图戒烟者可能更有可能使用电子烟、小雪茄或无烟烟草,并且对其广告的易感性更高。这凸显了规范与戒烟相关广告宣传的重要性,因为尚未证明其在此方面的有效性。